{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T20:59:24Z","timestamp":1776891564538,"version":"3.51.2"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T00:00:00Z","timestamp":1506297600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/203230\/2016"],"award-info":[{"award-number":["E-26\/203230\/2016"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12020-017-1424-0","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T02:58:01Z","timestamp":1506308281000},"page":"474-480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Somatostatin receptor subtype 1 might be a predictor of better response to therapy in medullary thyroid carcinoma"],"prefix":"10.1007","volume":"58","author":[{"given":"Daniel Barretto","family":"Kendler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Lucio","family":"Ara\u00fajo Jr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Alencar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Theresa","family":"de Souza Accioly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Alves","family":"Bulzico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cencita Cordeiro","family":"de Noronha Pessoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Andrade","family":"Accioly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terence Pires","family":"de Farias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flaia Paiva Proen\u00e7a Lobo","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana","family":"Corbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Vaisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6835-7108","authenticated-orcid":false,"given":"Fernanda","family":"Vaisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,25]]},"reference":[{"issue":"2","key":"1424_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1210\/jc.2014-3095","volume":"100","author":"EF Brutsaert","year":"2015","unstructured":"E.F. Brutsaert, A.J. Gersten, A.B. Tassler, M.I. Surks, Medullary thyroid cancer with undetectable serum calcitonin. J. Clin. Endocrinol. Metab. 100(2), 337\u2013341 (2015). \n                        https:\/\/doi.org\/10.1210\/jc.2014-3095","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"1424_CR2","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr.","year":"2015","unstructured":"S.A. Wells Jr., S.L. Asa, H. Dralle, R. Elisei, D.B. Evans, R.F. Gagel, N. Lee, A. Machens, J.F. Moley, F. Pacini, F. Raue, K. Frank-Raue, B. Robinson, M.S. Rosenthal, M. Santoro, M. Schlumberger, M. Shah, S.G. Waguespack, American Thyroid Association Guidelines Task Force on Medullary Thyroid, C., Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 25(6), 567\u2013610 (2015). \n                        https:\/\/doi.org\/10.1089\/thy.2014.0335","journal-title":"Thyroid."},{"issue":"1","key":"1424_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1067\/mhn.2003.2","volume":"128","author":"N Bhattacharyya","year":"2003","unstructured":"N. Bhattacharyya, A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma. Otolaryngol. Head. Neck. Surg. 128(1), 115\u2013123 (2003). \n                        https:\/\/doi.org\/10.1067\/mhn.2003.2","journal-title":"Otolaryngol. Head. Neck. Surg."},{"issue":"2","key":"1424_CR4","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1089\/thy.2014.0277","volume":"25","author":"SC Lindsey","year":"2015","unstructured":"S.C. Lindsey, I. Ganly, F. Palmer, R.M. Tuttle, Response to initial therapy predicts clinical outcomes in medullary thyroid cancer. Thyroid. 25(2), 242\u2013249 (2015). \n                        https:\/\/doi.org\/10.1089\/thy.2014.0277","journal-title":"Thyroid."},{"issue":"7","key":"1424_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/archsurg.2009.122","volume":"144","author":"SY Boostrom","year":"2009","unstructured":"S.Y. Boostrom, C.S. Grant, G.B. Thompson, D.R. Farley, M.L. Richards, T.L. Hoskin, I.D. Hay, Need for a revised staging consensus in medullary thyroid carcinoma. Arch. Surg. 144(7), 663\u2013669 (2009). \n                        https:\/\/doi.org\/10.1001\/archsurg.2009.122","journal-title":"Arch. Surg."},{"issue":"6","key":"1424_CR6","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/MPA.0b013e3181ebb4f0","volume":"39","author":"H Chen","year":"2010","unstructured":"H. Chen, R.S. Sippel, M.S. O\u2019Dorisio, A.I. Vinik, R.V. Lloyd, K. Pacak; North American Neuroendocrine Tumor, S., The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas. 39(6), 775\u2013783 (2010). \n                        https:\/\/doi.org\/10.1097\/MPA.0b013e3181ebb4f0","journal-title":"Pancreas."},{"issue":"7","key":"1424_CR7","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1210\/jcem.83.7.4955","volume":"83","author":"E Mato","year":"1998","unstructured":"E. Mato, X. Matias-Guiu, A. Chico, S.M. Webb, R. Cabezas, L. Berna, A. De Leiva, Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 83(7), 2417\u20132420 (1998). \n                        https:\/\/doi.org\/10.1210\/jcem.83.7.4955","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"1424_CR8","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/1097-0142(19890315)63:6<1189::AID-CNCR2820630625>3.0.CO;2-J","volume":"63","author":"F Pacini","year":"1989","unstructured":"F. Pacini, R. Elisei, S. Anelli, F. Basolo, A. Cola, A. Pinchera, Somatostatin in medullary thyroid cancer. In vitro and in vivo studies. Cancer 63(6), 1189\u20131195 (1989)","journal-title":"Cancer"},{"issue":"1","key":"1424_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(03)00235-9","volume":"1616","author":"LN Moller","year":"2003","unstructured":"L.N. Moller, C.E. Stidsen, B. Hartmann, J.J. Holst, Somatostatin receptors. Biochim. Biophys. Acta. 1616(1), 1\u201384 (2003)","journal-title":"Biochim. Biophys. Acta."},{"issue":"13","key":"1424_CR10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/0024-3205(95)02082-T","volume":"57","author":"YC Patel","year":"1995","unstructured":"Y.C. Patel, M.T. Greenwood, R. Panetta, L. Demchyshyn, H. Niznik, C.B. Srikant, The somatostatin receptor family. Life. Sci. 57(13), 1249\u20131265 (1995)","journal-title":"Life. Sci."},{"issue":"3","key":"1424_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1006\/frne.1999.0183","volume":"20","author":"YC Patel","year":"1999","unstructured":"Y.C. Patel, Somatostatin and its receptor family. Front. Neuroendocrinol. 20(3), 157\u2013198 (1999). \n                        https:\/\/doi.org\/10.1006\/frne.1999.0183","journal-title":"Front. Neuroendocrinol."},{"issue":"3","key":"1424_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.yfrne.2013.07.005","volume":"34","author":"M Theodoropoulou","year":"2013","unstructured":"M. Theodoropoulou, G.K. Stalla, Somatostatin receptors: from signaling to clinical practice. Front. Neuroendocrinol. 34(3), 228\u2013252 (2013). \n                        https:\/\/doi.org\/10.1016\/j.yfrne.2013.07.005","journal-title":"Front. Neuroendocrinol."},{"issue":"5","key":"1424_CR13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2265.2001.01175.x","volume":"54","author":"M Papotti","year":"2001","unstructured":"M. Papotti, U. Kumar, M. Volante, C. Pecchioni, Y.C. Patel, Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid. Clin. Endocrinol. (Oxf). 54(5), 641\u2013649 (2001)","journal-title":"Clin. Endocrinol. (Oxf)."},{"issue":"10","key":"1424_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/apm.12584","volume":"124","author":"M Herac","year":"2016","unstructured":"M. Herac, B. Niederle, M. Raderer, M. Krebs, K. Kaserer, O. Koperek, Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis. APMIS. 124(10), 839\u2013845 (2016). \n                        https:\/\/doi.org\/10.1111\/apm.12584","journal-title":"APMIS."},{"issue":"1","key":"1424_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6614-2-1","volume":"2","author":"H Pisarek","year":"2009","unstructured":"H. Pisarek, T. Stepien, R. Kubiak, E. Borkowska, M. Pawlikowski, Expression of somatostatin receptor subtypes in human thyroid tumors: the immunohistochemical and molecular biology (RT-PCR) investigation. Thyroid Res. 2(1), 1 (2009). \n                        https:\/\/doi.org\/10.1186\/1756-6614-2-1","journal-title":"Thyroid Res"},{"issue":"7","key":"1424_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.oraloncology.2013.03.443","volume":"49","author":"RM Tuttle","year":"2013","unstructured":"R.M. Tuttle, I. Ganly, Risk stratification in medullary thyroid cancer: moving beyond static anatomic staging. Oral. Oncol. 49(7), 695\u2013701 (2013). \n                        https:\/\/doi.org\/10.1016\/j.oraloncology.2013.03.443","journal-title":"Oral. Oncol."},{"issue":"11","key":"1424_CR17","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1111\/j.1582-4934.2010.01125.x","volume":"14","author":"M Cakir","year":"2010","unstructured":"M. Cakir, D. Dworakowska, A. Grossman, Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways. J. Cell. Mol. Med. 14(11), 2570\u20132584 (2010). \n                        https:\/\/doi.org\/10.1111\/j.1582-4934.2010.01125.x","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"1424_CR18","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s12020-015-0594-x","volume":"50","author":"D Mole","year":"2015","unstructured":"D. Mole, E. Gentilin, A. Ibanez-Costa, T. Gagliano, M.D. Gahete, F. Tagliati, R. Rossi, M.R. Pelizzo, G. Pansini, R.M. Luque, J.P. Castano, E. degli Uberti, M.C. Zatelli, The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells. Endocrine. 50(2), 442\u2013452 (2015). \n                        https:\/\/doi.org\/10.1007\/s12020-015-0594-x","journal-title":"Endocrine."},{"issue":"32","key":"1424_CR19","doi-asserted-by":"publisher","first-page":"28431","DOI":"10.1074\/jbc.M201261200","volume":"277","author":"AM Buchan","year":"2002","unstructured":"A.M. Buchan, C.Y. Lin, J. Choi, D.L. Barber, Somatostatin, acting at receptor subtype 1, inhibits Rho activity, the assembly of actin stress fibers, and cell migration. J. Biol. Chem. 277(32), 28431\u201328438 (2002). \n                        https:\/\/doi.org\/10.1074\/jbc.M201261200","journal-title":"J. Biol. Chem."},{"issue":"4","key":"1424_CR20","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0006-291X(02)02307-0","volume":"297","author":"MC Zatelli","year":"2002","unstructured":"M.C. Zatelli, F. Tagliati, D. Piccin, J.E. Taylor, M.D. Culler, M. Bondanelli, E.C. degli Uberti, Somatostatin receptor subtype 1-selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. Biochem. Biophys. Res. Commun. 297(4), 828\u2013834 (2002)","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"1424_CR21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11102-006-0270-5","volume":"9","author":"WW Herder de","year":"2006","unstructured":"W.W. de Herder, D.J. Kwekkeboom, R.A. Feelders, M.O. van Aken, S.W. Lamberts, A.J. van der Lely, E.P. Krenning, Somatostatin receptor imaging for neuroendocrine tumors. Pituitary. 9(3), 243\u2013248 (2006). \n                        https:\/\/doi.org\/10.1007\/s11102-006-0270-5","journal-title":"Pituitary."},{"issue":"5","key":"1424_CR22","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/j.1471-4159.2004.02402.x","volume":"89","author":"G Olias","year":"2004","unstructured":"G. Olias, C. Viollet, H. Kusserow, J. Epelbaum, W. Meyerhof, Regulation and function of somatostatin receptors. J. Neurochem. 89(5), 1057\u20131091 (2004). \n                        https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02402.x","journal-title":"J. Neurochem."},{"issue":"3","key":"1424_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1530\/EJE-07-0562","volume":"158","author":"GF Taboada","year":"2008","unstructured":"G.F. Taboada, R.M. Luque, L.V. Neto, O. Machado Ede, B.C. Sbaffi, R.C. Domingues, J.B. Marcondes, L.M. Chimelli, R. Fontes, P. Niemeyer, D.P. de Carvalho, R.D. Kineman, M.R. Gadelha, Quantitative analysis of somatostatin receptor subtypes (1-5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR. Eur. J. Endocrinol. 158(3), 295\u2013303 (2008). \n                        https:\/\/doi.org\/10.1530\/EJE-07-0562","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"1424_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/RLU.0000000000000628","volume":"40","author":"F Vaisman","year":"2015","unstructured":"F. Vaisman, P.H. Rosado de Castro, F.P. Lopes, D.B. Kendler, C.H. Pessoa, D.A. Bulzico, D. de Carvalho Leal, B. Vilhena, M. Vaisman, M. Carneiro, R. Corbo, Is there a role for peptide receptor radionuclide therapy in medullary thyroid cancer? Clin. Nucl. Med. 40(2), 123\u2013127 (2015). \n                        https:\/\/doi.org\/10.1097\/RLU.0000000000000628","journal-title":"Clin. Nucl. Med."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-017-1424-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1424-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-017-1424-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T11:31:02Z","timestamp":1510918262000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-017-1424-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,25]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1424"],"URL":"https:\/\/doi.org\/10.1007\/s12020-017-1424-0","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,25]]}}}